189 related articles for article (PubMed ID: 30580697)
1. PRELUDE Prospective Study of the Serranator Device in the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Popliteal Arteries.
Holden A; Hill A; Walker A; Buckley B; Merrilees S; Nowakowski P; Krzanowski M; Brodmann M
J Endovasc Ther; 2019 Feb; 26(1):18-25. PubMed ID: 30580697
[TBL] [Abstract][Full Text] [Related]
2. Prospective Study of Serration Angioplasty in the Infrapopliteal Arteries Using the Serranator Device: PRELUDE BTK Study.
Holden A; Lichtenberg M; Nowakowski P; Wissgott C; Hertting K; Brodmann M
J Endovasc Ther; 2022 Aug; 29(4):586-593. PubMed ID: 34802313
[TBL] [Abstract][Full Text] [Related]
3. Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial.
Iida O; Soga Y; Urasawa K; Saito S; Jaff MR; Wang H; Ookubo H; Yokoi H;
J Endovasc Ther; 2018 Feb; 25(1):109-117. PubMed ID: 29264999
[TBL] [Abstract][Full Text] [Related]
4. Treating Post-Angioplasty Dissection in the Femoropopliteal Arteries Using the Tack Endovascular System: 12-Month Results From the TOBA II Study.
Gray WA; Cardenas JA; Brodmann M; Werner M; Bernardo NI; George JC; Lansky A
JACC Cardiovasc Interv; 2019 Dec; 12(23):2375-2384. PubMed ID: 31806218
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
[TBL] [Abstract][Full Text] [Related]
6. Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain: 2-Year Results From the IN.PACT Global Study.
Micari A; Brodmann M; Keirse K; Peeters P; Tepe G; Frost M; Wang H; Zeller T;
JACC Cardiovasc Interv; 2018 May; 11(10):945-953. PubMed ID: 29798770
[TBL] [Abstract][Full Text] [Related]
7. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ
J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924
[TBL] [Abstract][Full Text] [Related]
8. Lower Extremity Revascularization Using Optical Coherence Tomography-Guided Directional Atherectomy: Final Results of the EValuatIon of the PantheriS OptIcal COherence Tomography ImagiNg Atherectomy System for Use in the Peripheral Vasculature (VISION) Study.
Schwindt AG; Bennett JG; Crowder WH; Dohad S; Janzer SF; George JC; Tedder B; Davis TP; Cawich IM; Gammon RS; Muck PE; Pigott JP; Dishmon DA; Lopez LA; Golzar JA; Chamberlin JR; Moulton MJ; Zakir RM; Kaki AK; Fishbein GJ; McDaniel HB; Hezi-Yamit A; Simpson JB; Desai A
J Endovasc Ther; 2017 Jun; 24(3):355-366. PubMed ID: 28393673
[TBL] [Abstract][Full Text] [Related]
9. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K
J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972
[TBL] [Abstract][Full Text] [Related]
10. Acute Outcomes With a Novel Plaque Modification System in Real-World Femoropopliteal Lesions.
Zeller T; Lopez L; Pigott JP
J Endovasc Ther; 2019 Jun; 26(3):333-341. PubMed ID: 31106694
[TBL] [Abstract][Full Text] [Related]
11. Results from the Tack Optimized Balloon Angioplasty (TOBA) study demonstrate the benefits of minimal metal implants for dissection repair after angioplasty.
Bosiers M; Scheinert D; Hendriks JM; Wissgott C; Peeters P; Zeller T; Brodmann M; Staffa R;
J Vasc Surg; 2016 Jul; 64(1):109-16. PubMed ID: 27139789
[TBL] [Abstract][Full Text] [Related]
12. Prospective Evaluation of the TIGRIS Vascular Stent Within a Modern Treatment Algorithm.
Werner M; Gomari-Grisar F; Belalcazar S; Hirschl M; Kalchhauser G; Al-Taiee B; Jäger N; Westhausser C; Tischler M; Tischler R
J Endovasc Ther; 2019 Oct; 26(5):637-642. PubMed ID: 31303096
[No Abstract] [Full Text] [Related]
13. One-Year Clinical Outcomes of the Legflow Drug-Coated Balloon for the Treatment of Femoropopliteal Occlusions Registry.
Stabile E; Gerardi D; Magliulo F; Zhelev D; Chervenkoff V; Taeymans K; Kotasov D; Goverde P; Giugliano G; Trimarco B; Esposito G
J Endovasc Ther; 2019 Feb; 26(1):26-30. PubMed ID: 30760132
[TBL] [Abstract][Full Text] [Related]
14. 12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment.
Steiner S; Willfort-Ehringer A; Sievert H; Geist V; Lichtenberg M; Del Giudice C; Sauguet A; Diaz-Cartelle J; Marx C; Ströbel A; Schult I; Scheinert D;
JACC Cardiovasc Interv; 2018 May; 11(10):934-941. PubMed ID: 29730375
[TBL] [Abstract][Full Text] [Related]
15. Safety and feasibility of adjunctive dexamethasone infusion into the adventitia of the femoropopliteal artery following endovascular revascularization.
Owens CD; Gasper WJ; Walker JP; Alley HF; Conte MS; Grenon SM
J Vasc Surg; 2014 Apr; 59(4):1016-24. PubMed ID: 24423476
[TBL] [Abstract][Full Text] [Related]
16. Six-Month Results From the Initial Randomized Study of the Ranger Paclitaxel-Coated Balloon in the Femoropopliteal Segment.
Bausback Y; Willfort-Ehringer A; Sievert H; Geist V; Lichtenberg M; Del Giudice C; Sauguet A; Diaz-Cartelle J; Marx C; Ströbel A; Schult I; Scheinert D;
J Endovasc Ther; 2017 Aug; 24(4):459-467. PubMed ID: 28558502
[TBL] [Abstract][Full Text] [Related]
17. 1-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease: Evidence From the SFA-Long Study.
Micari A; Vadalà G; Castriota F; Liso A; Grattoni C; Russo P; Marchese A; Pantaleo P; Roscitano G; Cesana BM; Cremonesi A
JACC Cardiovasc Interv; 2016 May; 9(9):950-6. PubMed ID: 27151609
[TBL] [Abstract][Full Text] [Related]
18. Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease.
Scheinert D; Micari A; Brodmann M; Tepe G; Peeters P; Jaff MR; Wang H; Schmahl R; Zeller T;
Circ Cardiovasc Interv; 2018 Oct; 11(10):e005654. PubMed ID: 30354636
[TBL] [Abstract][Full Text] [Related]
19. Impact of Scoring Balloons on Percutaneous Transluminal Angioplasty Outcomes in Femoropopliteal Lesions.
Horie K; Tanaka A; Taguri M; Inoue N
J Endovasc Ther; 2020 Jun; 27(3):481-491. PubMed ID: 32249658
[No Abstract] [Full Text] [Related]
20. Stent placement in the superficial femoral and proximal popliteal arteries with the innova self-expanding bare metal stent system.
Powell RJ; Jaff MR; Schroë H; Benko A; Diaz-Cartelle J; Müller-Hülsbeck S
Catheter Cardiovasc Interv; 2017 May; 89(6):1069-1077. PubMed ID: 28296239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
